James Williams, MS, DO, FACEP, describes the presentation of hepatic encephalopathy (HE) in patients and challenges associated with diagnosis.

Drs Arun Jesudian and James Williams share thoughts on patients with hepatic encephalopathy who are at risk of hospitalization, poorer patient and economic outcomes associated with readmission rates, and the impact of hepatic encephalopathy on quality of life.

An expert in emergency medicine outlines his approach to the clinical evaluation of hepatic encephalopathy.

Dr James Williams shares insight on factors leading to delays in hepatic encephalopathy (HE) diagnosis, the importance of early detection, and strategies to improve diagnosis in the in-patient setting.

Arun Jesudian, MD, and James Williams, MS, DO, FACEP, review the AASLD and EASL guideline approaches to the management of overt hepatic encephalopathy (HE) and comment on the grading of HE based on presentation.

James Williams, MS, DO, FACEP, comments on current treatment options and treatment selection for hepatic encephalopathy.

Drs Arun Jesudian and James Williams discuss treatment with lactulose and rifaximin for patients with hepatic encephalopathy and clinical data on their effect on hospital length of stay.

An expert in emergency medicine and a transplant hepatologist consider common infections that patients with hepatic encephalopathy should be evaluated for.

Arun Jesudian, MD, and James Williams, MS, DO, FACEP, highlight precipitating factors for HE and medication compliance for the condition.

James Williams, MS, DO, FACEP, provides insight on the importance of medication reconciliation when managing patients with hepatic encephalopathy.

A transplant hepatologist shares advice for emergency department physicians and clinicians to improve the diagnosis and treatment of hepatic encephalopathy.

Drs Arun Jesudian and James William discuss approaches for proper discharge planning and transition of care and how this can reduce readmission for patients with hepatic encephalopathy.